Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer have?
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer has 239 citations in the OpenAlex counts ScholarIQ stores.
When was Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer published?
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer has 2019 year in the ScholarIQ index.
What is the open-access status of Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer?
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer has green oa status in the ScholarIQ index.
What is the DOI of Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer?
The DOI for Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer is on the source record.
What is the PMID of Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer?
The PMID for Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer is on the source record.
What is the OpenAlex record for Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer?
The OpenAlex for Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer is on the source record.